US Biomedical Advanced Research and Development Authority

US health agency awards $9.27 million contract to bio-tech firm to test a Covid vaccine in pill form

The following is from The Vaccine Reaction. Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb

US health agency awards $9.27 million contract to bio-tech firm to test a Covid vaccine in pill form Read More »

Scroll to Top